Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 0 | 0 | 4,318,000 | 3,870,000 | 2,497,000 |
| Cost of Goods | N/A | N/A | 2,281,000 | 2,028,000 | 1,661,000 |
| Gross Profit | N/A | N/A | 2,037,000 | 1,842,000 | 836,000 |
| Operating Expenses | 13,826 | 0 | 2,677,000 | 1,778,000 | 855,000 |
| Operating Income | -13,826 | N/A | -640,000 | 64,000 | -19,000 |
| Interest Expense | 0 | 0 | 625,000 | 546,000 | 223,000 |
| Other Income | -1,033 | 0 | -24,000 | 55,000 | -26,000 |
| Pre-tax Income | -14,859 | 0 | -1,289,000 | -427,000 | -268,000 |
| Income Tax | N/A | N/A | -45,000 | -474,000 | -1,000 |
| Net Income Continuous | -14,859 | N/A | -1,244,000 | 47,000 | -267,000 |
| Minority Interests | N/A | N/A | -4,000 | -3,000 | 6,000 |
| Net Income | $-14,859 | $N/A | $-1,240,000 | $50,000 | $-273,000 |
| EPS Basic Total Ops | -6.08 | N/A | -9.78 | 0.22 | -2.65 |
| EPS Basic Continuous Ops | -6.08 | N/A | -9.64 | 0.38 | -2.54 |
| EPS Diluted Total Ops | -6.08 | N/A | -9.78 | 0.22 | -2.65 |
| EPS Diluted Continuous Ops | -6.08 | N/A | -9.64 | 0.37 | -2.54 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -2.54 | 1.12 | -1.27 |
| EBITDA(a) | $-13,555 | $N/A | $70,000 | $640,000 | $273,000 |